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Specific-pathogen-free Hartley guinea pigs were maintained on isocaloric-purified diets either adequate
(30%) or moderately deficient (10%) in protein. Half of each diet group was vaccinated with viable
Mycobacterium bovis BCG. Six weeks later, all animals were challenged by the respiratory route with virulent
Mycobacterium tuberculosis H37Rv. At intervals of 1, 2, and 3 weeks postchallenge, guinea pigs from each diet
and vaccination group were skin tested with tuberculin and sacrificed. Protein deficiency resulted in loss of
tuberculin hypersensitivity. Vaccination with M. bovis BCG protected control animals, as determined by
significant reductions in the number of M. tuberculosis H37Rv organisms recovered from lungs, spleen, and
bronchotracheal lymph nodes 2 and 3 weeks postchallenge. Based upon the same criteria, the degree of
protection afforded protein-deficient animals by M. bovis BCG vaccine ranged from partial (spleen and lymph
nodes) to none at all (lungs). Approximately the same numbers of tubercle bacilli were recovered from
nonvaccinated guinea pigs in both diet groups. Protein deficiency appears to impair M. bovis BCG-induced
immunity while not affecting primary pulmonary infection with virulent M. tuberculosis.
Tuberculosis is a major cause of morbidity and mortality
in the developing world today despite the availability of a
vaccine, Mycobacterium bovis BCG. While there is very
good evidence for the efficacy of M. bovis BCG in protecting
vaccine recipients against clinical tuberculosis, the recent
field trial failure in South India suggests that unknown
environmental or host factors may render M. bovis BCG less
efficacious in certain Third World populations (2, 19).
Malnutrition coexists with tuberculosis in many parts of
the world in which vaccination is the only cost-effective
means of controlling the disease. Dietary deficiencies of
specific nutrients have been associated with alterations in
immunological competence in humans and experimental
animals (1, 6). Cell-mediated immunity in general and thy-
mus-dependent (T) lymphocyte numbers and functions in
particular appear to be predictably and profoundly altered in
the malnourished host (8, 9). The extrapolation of these
observations to T cell-mediated infectious disease resist-
ance, however, has not been straightforward. Some macro-
phage-dependent host defense mechanisms are apparently
unaffected or even enhanced in nutritionally deprived indi-
viduals (13, 20). Given the central role ofT lymphocytes and
macrophage activation by their products in resistance
against tuberculosis, it is likely that nutritional deficiencies
would alter mycobacterial immunity (2, 3, 7). Early studies
in malnourished, M. bovis BCG-vaccinated children demon-
strated that such children did not develop normal tuberculin
skin reactivity after vaccination and presumably were not as
protected against virulent challenge (6, 11, 16). The latter
hypothesis has never been tested in humans or experimental
animals.
We have adapted a guinea pig model of experimental
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pulmonary tuberculosis to study the effects of dietary defi-
ciencies on M. bovis BCG vaccine efficacy (17). Our previ-
ous results revealed specific lesions in the immune responses
of protein-deficient guinea pigs vaccinated with M. bovis
BCG. In general, protein-malnourished guinea pigs failed to
mount a significant tuberculin reaction, even to increased
doses of tuberculin, although these animals eventually con-
trolled infection with M. bovis BCG and other attenuated
mycobacteria (12, 10). The experiments we describe here
were designed to determine whether protein-malnourished
guinea pigs could be protected by M. bovis BCG vaccine
against respiratory challenge with virulent Mycobacterium
tuberculosis.
(This work was presented in part at the 85th Annual
Meeting of the American Society for Microbiology, Las
Vegas, Nev., 3 to 7 March, 1985.)
MATERIALS AND METHODS
Experimental animals. Outbred, albino, specific-pathogen-
free female guinea pigs, weighing 150 to 200 g each, were
obtained from a commercial source (Hartley-COBS,
Crl:(HA)BR; Charles River Breeding Laboratories, Inc.,
Wilmington, Mass.). They were housed individually in
polycarbonate cages on stainless-steel grid floors and
provided food in stainless-steel feeders and tap water ad
libitum. Each animal was randomly assigned to an
experimental diet and vaccination treatment group. Body
weights were recorded weekly during the experiment.
Experimental diets. The experimental diets, based upon
ovalbumin as the protein source, were designed to meet
current recommended nutritional requirements for guinea
pigs (14). The biotin content of the diet was increased to
counter the effects of avidin, a biotin-binding protein found
in ovalbumin. Two diets representing an adequate level of
protein (30%) and a protein-deficient level (10%) were ob-
tained from a commercial source (Dyets, Inc., Bethlehem,
Pa.). The diets were isocaloric, with the proportion of corn
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TABLE 1. Influence of diet on growth and protein statuSa
Dietary Vaccination Body weight (g) at wk: Serum albumin (g/dl) at wk:
treatment statusb 1 2 3 1 2 3
Control VACC 387 ± 32c 391 ± 57" 413 ± 17C 3.62 ± 0.17c 3.35 ± 0.18c 2.93 ± 0.16c
NV 368 ± 22" 365 ± 20" 342 ± 24d 3.57 ± 0.30c 3.24 ± 0.16" 2.88 ± 0.10c
Low protein VACC 287 ± 23d 297 ± 14d 257 ± 25e 2.77 ± 0.09d 2.90 ± 0.13d 2.74 ± 0.14c"d
NV 262 ± 21d 248 ± 18e 230 ± 21e 3.05 ± 0.07d 2.87 ± 0.22d 2.61 ± 0.09d
a Values are mean + standard error of the mean of four to six observations at indicated week post-respiratory challenge with virulent M. tuberculosis.
b VACC, Vaccinated guinea pigs; NV, nonvaccinated guinea pigs.
cAd,e Means within each interval labeled by the same superscript letter are not statistically different (P > 0.05); means labeled with different superscript letters
are statistically different.
starch and ovalbumin varying inversely to provide the
desired protein content. The formulation of the diets has
been published previously (12). All animals were given a
mixture of the fully supplemented diet (30% protein) and
decreasing proportions of powdered commercial guinea pig
stock diet (Ralston Purina Co., St. Louis, Mo.) over a
2-week adaptation period before assignment to one of the
experimental diets. The food was given as a powder, and
fresh diet was provided every other day. Food intake was
monitored periodically throughout the study.
M. bovis BCG vaccination. On the same day the experi-
mental diets were started, half of the guinea pigs in each diet
treatment were vaccinated with viable M. bovis BCG vac-
cine (Copenhagen 1331; Statens Seruminstitut, Copenhagen,
Denmark). Each animal received 0.1 ml of saline solution
containing approximately 103 viable bacilli subcutaneously
over the left inguinal region. The viability of the vaccine was
determined by plating appropriate dilutions on M7H10 agar
(Difco Laboratories, Detroit, Mich.).
Respiratory infection. M. tuberculosis H37Rv (ATCC
27294) was obtained from the American Type Culture Col-
lection, Rockville, Md. The challenge inoculum was pre-
pared and stored at -70°C by a published procedure (5).
After 6 weeks on the experimental diets (i.e., 6 weeks
postvaccination with M. bovis BCG), all guinea pigs were
infected via the respiratory route in an exposure chamber
described previously (10, 20). The infection was carried out
in a biohazard facility for use with class 3 human microbial
pathogens. The concentration of viable M. tuberculosis
H37Rv organisms in the nebulizer fluid was adjusted empir-
ically to result in the inhalation and retention of about 102
viable mycobacteria per guinea pig. The viable count was
determined by plating appropriate dilutions of the challenge
culture on M7H10 agar plates (Difco). The actual challenge
level was estimated from the number of primary tubercles
observed grossly in the lungs of nonvaccinated animals at 3
weeks postinfection. Diet did not influence significantly the
number of tubercle bacilli inhaled and retained by this
criterion. Groups of guinea pigs, selected randomly from
each of the vaccination and dietary treatments, were ex-
posed repeatedly to result in uniform, reproducible infection
of all animals with mycobacteria (18, 20).
PPD skin tests. One day before sacrifice, guinea pigs
received two intradermal injections of 0.1 ml of solution
containing either 5 or 100 tuberculin units (TU) of purified
protein derivative (PPD) (PPD-RT23; Statens Seruminstitut,
Copenhagen, Denmark) on a shaved area of the side. The
reactions were measured with a transparent plastic ruler 24 h
later, and the mean diameter of induration was recorded in
millimeters.
Necropsy procedure. One, two, and three weeks after
respiratory infection with virulent M. tuberculosis H37Rv,
groups of four to six guinea pigs from each treatment were
killed by cervical dislocation. A blood sample (5 to 7 ml) was
drawn immediately from each animal by cardiac puncture
into a 10-ml syringe. The serum was separated from each
sample and stored at -20°C. The right lower lobe of the lung,
the spleen, and the bronchotracheal lymph nodes were
removed aseptically, placed in sterile petri dishes, and
weighed. All infected tissues were handled in a biohazard
hood with appropriate precautions for protection of person-
nel. The tissues were then homogenized separately in 4.5 ml
of sterile physiologic saline in Teflon-glass homogenizers.
Appropriate dilutions were inoculated onto duplicate M7H1O
agar plates which were incubated at 37°C for 3 to 4 weeks.
The number of colonies was counted, and the results were
expressed as mean log10 viable organisms per gram (wet
weight) of tissue to account for differences in organ size due
to dietary deficiency and sampling procedures.
Statistical analysis. The analysis of variance was used to
test for the effects of the treatment variables (diet and
vaccination) on the dependent variables (extent of disease
and delayed hypersensitivity). Mean differences between
treatment groups were tested for statistical significance by
Student's t test or Duncan's new multiple range test. The
accepted level of probability was set at 95% for all tests.
RESULTS
Dietary influence on nutritional status. The low-protein diet
had the expected effects on growth and metabolism of guinea
pigs (Table 1). Body weights of protein-deficient animals
were significantly lower at all sacrifice intervals. Nonvac-
cinated animals appeared to lose more weight than vacci-
nated animals in both diet groups. The significant reduction
in serum albumin concentrations in the low-protein group is
evidence of the protein-deficient status of those guinea pigs.
No differences in food intake were noted between the diet
groups at any time during the experiment.
Effect of diet and vaccination on tuberculin hypersensitivity.
Dermal reactions in both doses of tuberculin were pro-
foundly impaired in protein-deficient guinea pigs. The same
treatment effects were seen in response to both the 5- and
100-TU doses, although the absolute reaction size and the
magnitude of the differences between treatments were
greater with the larger dose of tuberculin, and therefore only
those data are presented (Fig. 1). Vaccinated guinea pigs
consuming the control diet exhibited strong positive reac-
tions at all sacrifice intervals, while their nonvaccinated
counterparts developed significant dermal reactions to PPD
as their disease developed. In contrast, protein-deficient
animals were hyporesponsive at all intervals. Neither previ-
ous vaccination with M. bovis BCG nor extensive replication
of virulent M. tuberculosis was accompanied by significant
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FIG. 1. Influence of dietary protein and M. bovis BCG vaccina-
tion on delayed hypersensitivity reactions to 100-TU PPD in vacci-
nated (open symbols) and nonvaccinated (solid symbols) guinea pigs
maintained on either normal (squares) or protein-deficient (circles)
diets and challenged at zero time with virulent M. tuberculosis
H37Rv; mean ± standard error of the mean of four to six animals per
data point is shown.
delayed hypersensitivity reactions to a 100-TU dose of
tuberculin.
Impact of diet on protective efficacy of M. bovis BCG
vaccine. Vaccine-induced protection was defined as a signif-
icant reduction in the number of virulent M. tuberculosis
organisms recovered quantitatively from the tissues. In the
lung (Fig. 2), vaccination with M. bovis BCG conferred
protection on normally nourished guinea pigs, as evidenced
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FIG. 2. Effect of dietary protein and M. bovis BCG vaccination
on the number of viable M. tuberculosis H37Rv organisms recov-
ered from the lungs of vaccinated (open symbols) and nonvaccinated
(solid symbols) guinea pigs maintained on either normal (squares) or
protein-deficient (circles) diets; mean + standard error of the mean
of four to six animals per data point is shown.
by the 10- to 100-fold reduction in the number of virulent
tubercle bacilli, compared with their nonvaccinated counter-
parts at 2- and 3-week intervals. Protein deficiency, on the
other hand, completely eliminated any benefit from prior
vaccination. There was no difference between the bacillary
loads in the lungs of M. bovis BCG-vaccinated, low-protein
animals and either nonvaccinated group at any sacrifice
interval. In the spleen (Fig. 3), similar results were obtained.
Compared with animals consuming the control diet, protein-
deprived guinea pigs were significantly less protected by M.
bovis BCG vaccination, although the loss of protection in the
spleen was partial rather than complete. Figure 4 illustrates
the effects of dietary protein and vaccination on the number
of virulent M. tuberculosis organisms in the lymph nodes
draining the lungs. Both vaccinated groups had significantly
fewer organisms in their lymph nodes 2 weeks postchal-
lenge, while this protection had begun to wane by 3 weeks in
the protein-malnourished group. There were no significant
differences in the bacillary loads of protein-deprived vacci-
nated and nonvaccinated guinea pigs at the last interval. In
all organs, no dietary influence was observed on the ability
of nonvaccinated animals to control a primary, pulmonary
infection with virulent tubercle bacilli.
DISCUSSION
We have demonstrated that chronic, moderate dietary
protein deficiency impairs the ability of M. bovis BCG
vaccine to protect guinea pigs against respiratory challenge
with virulent M. tuberculosis H37Rv. Protein deprivation
was characterized by weight loss or reduced growth velocity
and modest but statistically significant reductions in the
concentration of serum albumin (Table 1). Protein-deprived
animals were incapable of mounting significant delayed
hypersensitivity reactions even to a large dose of tuberculin
(100 TU) and even in the presence of extensive, extra-
pulmonary tuberculosis (Fig. 1). Although we did not skin
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FIG. 3. Effect of dietary protein and M. bovis BCG vaccination
on the number of viable M. tuberculosis H37Rv organisms recov-
ered from the spleens of vaccinated (open symbols) and nonvac-
cinated (solid symbols) guinea pigs maintained on either normal
(squares) or protein-deficient (circles) diets; mean + standard error
of the mean of four to six animals per data point is shown.
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FIG. 4. Effect of dietary protein and M. bovis BCG vaccination
on the number of viable M. tuberculosis H37Rv organisms recov-
ered from the bronchotracheal lymph nodes of vaccinated (open
symbols) and nonvaccinated (solid symbols) guinea pigs maintained
on either normal (squares) or protein-deficient (circles) diets; mean
± standard error of the mean of four to six animals per data point is
shown.
test animals prior to respiratory challenge, previous experi-
ence indicates that the protein-malnourished guinea pigs
would have been responsive to PPD with reactions similar
to those seen at 1 week (12). These observations confirm
our previous reports of tuberculin anergy in protein-
malnourished guinea pigs infected with M. bovis BCG and
attenuated M. tuberculosis H37Ra (10, 12) and support the
contention that malnutrition interferes with the diagnostic
usefulness of PPD skin tests in individuals with clinical
tuberculosis (D. N. McMurray, Editorial, Chest 77:4-5,
1980).
Among the most consistent and predictable reports of
impaired cell-mediated immune function in malnourished
humans have been the observations of failure to develop
normal tuberculin skin reactivity after M. bovis BCG vacci-
nation (6, 11, 16). While it is tempting to suggest that lack of
conversion to PPD postvaccination implies that the vaccine
has been unsuccessful in eliciting a protective response in
the malnourished vaccine recipient, that hypothesis has
never been formally tested either in human field trials or in
experimental animals.
Using a guinea pig model similar to the one described
here, Smith and his colleagues (4, 18) have demonstrated
that successful vaccination with M. bovis BCG results in
control of mycobacterial accumulation in the primary lung
lesions as well as limitation of bacillemic spread of virulent
organisms to the spleen and the lymph nodes. A statistically
significant inverse correlation has been established between
the number of viable M. tuberculosis H37Rv organisms
recovered from the lungs between 3 and 5 weeks postchal-
lenge and the ultimate survival of vaccinated and nonvac-
cinated guinea pigs (20). Based upon that rationale, we
observed that M. bovis BCG did not protect protein-deficient
guinea pigs against virulent M. tuberculosis. The loss of
vaccine-induced protection was complete in the lung and
partial but significant in the spleen and the lymph nodes
draining the lung. It appears that protein deprivation not
only prevents control of mycobacterial accumulation in the
pulmonary lesions but interferes with the ability of vacci-
nated animals to limit extrapulmonary dissemination. Al-
though we believe that these data are predictive of the
ultimate outcome of infection, studies of longer challenge-
sacrifice intervals may be desirable to confirm the deleteri-
ous effect of protein deficiency on vaccine efficacy.
Given the failure of protein-deficient guinea pigs to mount
a protective immune response after vaccination with M.
bovis BCG, it was surprising to observe no effect of diet on
the course of primary tuberculosis in nonvaccinated animals.
Identical numbers of virulent mycobacteria were recovered
from lung, spleen, and lymph nodes of low-protein and
control, nonvaccinated groups. We had observed previously
that protein-deficient guinea pigs ultimately controlled pri-
mary infections with M. bovis BCG or attenuated M. tuber-
culosis H37Ra as successfully as normally nourished animals
(10, 12). In those experiments, as in the ones reported here,
control of mycobacterial populations in nonvaccinated ani-
mals was seen in the absence of significant tuberculin
hypersensitivity. The development of apparently effective
resistance to progressive tuberculosis has been observed
occasionally in anergic patients (McMurray, Editorial,
Chest, 1980). These observations suggest that dermal reac-
tivity and antimicrobial resistance in tuberculosis may be
dissociable events, possibly mediated by different T lympho-
cyte subpopulations, as reported in mice (15).
The extrapolation of these results to the effects of malnu-
trition on M. bovis BCG vaccine efficacy in human popula-
tions must be qualified. Variables such as the severity and
chronicity of protein deprivation, the virulence of the pre-
valent strains of M. tuberculosis, and the endpoint used to
define protection (quantitative reduction of bacillary loads
versus absence of clinical tuberculosis) might affect the
conclusions reached if a similar study were carried out in
humans. However, the fact that our observations were made
in an animal model designed specifically to approximate the
relevant human condition, with respect to both diet and
infection, suggests that nutritional variables may have con-
tributed to previous failures of M. bovis BCG vaccine in
human trials.
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